IRIS
LOMBARDI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.777
EU - Europa 3.628
AS - Asia 1.380
SA - Sud America 36
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 11
OC - Oceania 4
Totale 11.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.655
CN - Cina 1.215
IT - Italia 565
DE - Germania 541
SE - Svezia 535
FI - Finlandia 504
IE - Irlanda 484
NL - Olanda 448
UA - Ucraina 294
GB - Regno Unito 140
CA - Canada 113
TR - Turchia 56
FR - Francia 43
IN - India 34
IR - Iran 23
BE - Belgio 17
EU - Europa 16
VN - Vietnam 16
ES - Italia 11
BR - Brasile 10
CO - Colombia 9
JP - Giappone 8
MX - Messico 8
CH - Svizzera 7
AR - Argentina 6
CL - Cile 6
EG - Egitto 6
RO - Romania 5
TH - Thailandia 5
AT - Austria 4
KR - Corea 4
NO - Norvegia 4
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
IQ - Iraq 3
MY - Malesia 3
PL - Polonia 3
RU - Federazione Russa 3
AU - Australia 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HK - Hong Kong 2
IL - Israele 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
DZ - Algeria 1
ID - Indonesia 1
KH - Cambogia 1
LK - Sri Lanka 1
NP - Nepal 1
PR - Porto Rico 1
SG - Singapore 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 11.852
Salva come PNG Salva come JPEG
Città #
Chandler 1.523
Jacksonville 663
Millbury 595
Princeton 509
Amsterdam 425
Nanjing 419
Wilmington 330
Beijing 193
Naples 191
Woodbridge 156
Nanchang 149
Boston 146
Ottawa 99
Norwalk 94
Shenyang 77
Ann Arbor 63
Hebei 62
Napoli 61
Jiaxing 59
Falls Church 56
Tianjin 52
Houston 50
Kunming 43
Changsha 39
Boardman 38
Redwood City 34
Indiana 29
Dublin 28
San Mateo 24
Redmond 20
Lanzhou 19
Ardabil 18
Augusta 18
Des Moines 16
Dong Ket 16
Jinan 16
New York 14
Milan 13
Dearborn 12
Rome 12
San Francisco 12
Shanghai 12
Tappahannock 12
Yellow Springs 12
Changchun 11
Hangzhou 11
Istanbul 11
Toronto 11
Leawood 10
Ningbo 9
Duncan 8
Orange 7
Zhengzhou 7
Courcelles 6
Paris 6
Casalbore 5
Fremont 5
Monfalcone 5
Simi Valley 5
Aracaju 4
Bangalore 4
Casoria 4
Frankfurt am Main 4
Guangzhou 4
Monmouth Junction 4
Oslo 4
San Prisco 4
Taizhou 4
Torino 4
Venezia 4
Basel 3
Buenos Aires 3
Chatsworth 3
Cleveland 3
Dogliani 3
Fuzhou 3
Heidelberg 3
Lappeenranta 3
Madrid 3
San Diego 3
Vellore 3
Vollezele 3
Albersweiler 2
Athens 2
Baghdad 2
Bagheria 2
Baiut 2
Bologna 2
Bratislava 2
Bronx 2
Cambridge 2
Casalecchio Di Reno 2
Catania 2
Cava De' Tirreni 2
Chengdu 2
Deventer 2
Downers Grove 2
Enterprise 2
Fairfield 2
Fargo 2
Totale 6.662
Salva come PNG Salva come JPEG
Nome #
Systemic complications of acromegaly: epidemiology, pathogenesis, and management 393
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 73
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 66
A protein family immunorelated to a sperm-binding protein and its regulation in human semen. 64
Antipituitary antibodies in idiopathic hyperprolactinemic patients 63
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 58
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 57
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 56
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 55
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 55
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 53
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 53
Thyroid function and morphology after a successful kidney transplantation. 52
GH INSUFFICIENCY IN OBESE PATIENTS. 52
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 52
CORRELATION BETWEEN SEMINAL CARNITINE AND FUNCTIONAL CHARACTERISTICS IN MEN WITH SEMEN DYSFUNCTION OF VARIOUS ORIGINS. 51
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 51
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 51
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 50
Subclinical hyperthyroidism: clinical features and treatment options. 49
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 49
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 48
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 48
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 48
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 47
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 46
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 46
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 45
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 45
Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins 44
Effects of neridronate treatment in elderly women with osteoporosis 44
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 44
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 44
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 44
Cardiopulmonary impairment in young women with polycystic ovary syndrome 44
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 43
Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. 43
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. 43
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease 42
Identification and preliminary characterization of a sperm-binding protein in normal human semen 42
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. 42
Advances in the treatment of prolactinomas 42
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. 42
L'ESPOSIZIONE AMBIENTALE è UN FATTORE DI RISCHIO MASCHILE? 41
ANP, AVP, AND PITUITARY-THYROID AXIS IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ACUTE RESPIRATORY FAILURE. 41
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 41
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 41
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. 41
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. 40
Hypertension in acromegaly and in the normal population: prevalence and determinants 40
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 40
Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD) 40
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. 39
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 39
Endocrine dysfunction in patients with Fabry disease 39
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 39
Cushing's syndrome: aftermath of the cure. 39
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 38
Acromegalic axial arthropathy: a clinical case-control study 38
Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. 37
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 37
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 37
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 37
Role of IGF-I on PTH effects on bone. 37
Pegvisomant in acromegaly: why, when, how 36
Human seminal plasma proteins: identification and preliminary characterization of a sperm coating antigen (h-SCA) protein in physiological and pathological conditions. 36
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 36
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 36
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 36
Appropriate use of stimulation tests and insulin-like growth factor-I in obesity 35
Acromegaly 35
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 35
Cushing's syndrome 35
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas 35
Changes in insulin levels following 6-month treatment with recombinant human growth hormone in growth hormone-deficient adults. 35
Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy. 35
Growth hormone status in morbidly obese subjects and correlation with body composition 34
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 34
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 34
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 34
Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency. 34
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 34
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers 33
A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region 33
Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas 33
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 33
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 33
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 33
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 33
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 33
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 33
ASSOCIATION OF EARLY CAROTID ATHEROSCLEROSIS WITH HYPERINSULINEMIA AND LOW DHEA(S) IN NORMOTENSIVE SEVERE OBESE WOMEN. 33
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 32
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 32
PRL secreting adenomas in male patients 32
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 32
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 32
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 32
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 32
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 32
Totale 4.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019932 0 0 6 6 20 485 336 3 1 4 2 69
2019/20201.473 576 31 65 4 70 7 10 8 7 89 180 426
2020/20211.217 22 62 151 72 66 284 85 28 122 66 198 61
2021/20223.265 55 22 18 39 83 329 44 109 505 257 591 1.213
2022/20233.426 571 318 114 292 403 341 18 264 460 444 155 46
2023/2024760 91 354 315 0 0 0 0 0 0 0 0 0
Totale 12.288